Which organs are most commonly affected? What’s the impact of RA therapies on comorbidities? Answers here.
Deucravacitinib Improves Patient-Reported Outcomes in Active Psoriatic Arthritis
Emerging Agents in the Treatment of Rheumatic Diseases
Early-Onset IBD Linked to Greater Risk of Diseases with Possible Autoimmune Pathogenesis
Challenges with Step Therapy Protocols in Treating Rheumatoid Arthritis
At-Risk RA Individuals Have Different Views on Preventive Measures
Thiocyanate Exposure Linked to Greater Arthritis Risk, Heightened Inflammation Indicators